BOOM
Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| Multiple Sclerosis |
📓
Dietary Supplements on Controlling Multiple Sclerosis Symptoms and Relapses: Current Clinical Evidence and Future Perspectives. Medicines (Basel, Switzerland) (Medicines (Basel) ) Vol: 6 Issue 3 Pages: Pub: 2019 Sep 12 Epub: 2019 Sep 12 Authors Tryfonos C , Mantzorou M , Fotiou D , Vrizas M , Vadikolias K , Pavlidou E , Giaginis C , Html Article Publication |
| Multiple Sclerosis |
📓
Serum vitamin D level is associated with speed of processing in multiple sclerosis patients. The Journal of steroid biochemistry and molecular biology (J Steroid Biochem Mol Biol ) Vol: 200 Issue Pages: 105628 Pub: 2020 Feb 19 Epub: 2020 Feb 19 Authors Darwish H , Farran N , Hannoun S , Tadros N , Yamout B , El Ayoubi NK , Khoury SJ , Publication Publication |
| Multiple Sclerosis |
📓
Associations of serum 25(OH) vitamin D levels with clinical and radiological outcomes in multiple sclerosis, a systematic review and meta-analysis. Journal of the neurological sciences (J Neurol Sci ) Vol: 411 Issue Pages: 116668 Pub: 2020 Jan 25 Epub: 2020 Jan 25 Authors Martínez-Lapiscina EH , Mahatanan R , Lee CH , Charoenpong P , Hong JP , Publication Publication |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
